Haemonetics HAE Hospital — Cost of goods sold

Other segment segments

Similar metrics at other companies

PGHealth Care — Cost of products sold

$1.28B+7.3%

CVSHealth Care Benefits — Cost of products sold

$0—

OSISHealthcare Division — Cost of Goods Sold

$20.17M-6.9%

IFFHealth & Biosciences — Cost of Product and Service Sold

$327M+9.7%

CVSHealth Services — Cost of products sold

$44.72B+11.5%

IFFHealth & Biosciences — Cost of Sales

$327M+9.7%

Questions, answered.

What is Haemonetics's hospital — cost of goods sold?

Haemonetics (HAE) reported hospital — cost of goods sold of $54.59M in Q1 2026.

How has Haemonetics's hospital — cost of goods sold changed year-over-year?

Haemonetics's hospital — cost of goods sold increased by 0.3% year-over-year, from $54.42M to $54.59M.

What is the long-term trend for Haemonetics's hospital — cost of goods sold?

Over 3 years (2023 to 2026), Haemonetics's hospital — cost of goods sold has grown at a 11.2% compound annual growth rate (CAGR), from $147.83M to $203.23M.

What does hospital — cost of goods sold mean?

Includes the direct costs attributable to the production and delivery of products sold by the hospital segment, such as raw materials and manufacturing labor. Analyzing this metric helps determine the segment's gross margin and production efficiency.